Moolec Science SA (MLEC)
1.30
-0.02
(-1.52%)
USD |
NASDAQ |
May 10, 16:00
1.27
-0.03
(-2.31%)
After-Hours: 20:00
Moolec Science Net Income (Quarterly): -1.784M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.784M |
| September 30, 2023 | -1.591M |
| June 30, 2023 | -2.748M |
| March 31, 2023 | -0.3586M |
| Date | Value |
|---|---|
| December 31, 2022 | -47.96M |
| September 30, 2022 | -0.7214M |
| June 30, 2022 | -1.519M |
| March 31, 2022 | -1.167M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-47.96M
Minimum
Dec 2022
-0.3586M
Maximum
Mar 2023
-7.231M
Average
-1.555M
Median
Net Income (Quarterly) Benchmarks
| Alvotech | -276.56M |
| Procaps Group SA | 8.194M |
| Sunshine Biopharma Inc | -1.25M |
| Bio-Path Holdings Inc | -3.372M |
| Palisade Bio Inc | -2.971M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.2521M |
| Total Expenses (Quarterly) | 2.045M |
| EPS Diluted (Quarterly) | -0.05 |
| Enterprise Value | 54.85M |
| Gross Profit Margin (Quarterly) | 92.05% |
| Profit Margin (Quarterly) | -707.4% |
| Earnings Yield | -10.00% |